Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Global STD testing market overview
• Market sizing 2017
• Global STD testing market

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY TESTING DEVICES
• Global STD testing market by testing devices
• Comparison by testing devices
• Global STD testing market by laboratory testing devices
• Global STD testing market by POC testing devices
• Market opportunity by testing devices

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• STD testing market in Americas
• STD testing market in EMEA
• STD testing market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• High demand for POC testing
• Rising awareness regarding HIV
• Increasing importance of promotional activities

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• bioMerieux
• Bio-Rad Laboratories
• F. Hoffmann La Roche
• Other prominent vendors
• Company
• Description

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Validation techniques employed for market sizing 2017
Exhibit 06: Global STD testing market 2017-2022 ($ billions)
Exhibit 07: Global STD testing market: Year-over-year (YoY) growth 2018-2022 (%)
Exhibit 08: Five forces analysis 2017
Exhibit 09: Five forces analysis 2022
Exhibit 10: Bargaining power of buyers
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition: Five forces 2017
Exhibit 16: Market condition: Five forces 2022
Exhibit 17: Global STD testing market by testing devices 2017-2022 (%)
Exhibit 18: Comparison by testing devices
Exhibit 19: Global STD testing market by laboratory testing devices 2017-2022 ($ billions)
Exhibit 20: Global STD testing market by laboratory testing devices: YoY growth 2018-2022 (%)
Exhibit 21: Global STD testing market by POC testing devices 2017-2022 ($ billions)
Exhibit 22: Global STD testing market by POC testing devices: YoY growth 2018-2022 (%)
Exhibit 23: Market opportunity by testing devices
Exhibit 24: Customer landscape
Exhibit 25: Global STD testing market by geography 2017-2022 (%)
Exhibit 26: Regional comparison
Exhibit 27: STD testing market in Americas 2017-2022 ($ billions)
Exhibit 28: Americas: YoY growth 2018-2022 (%)
Exhibit 29: Top three countries in Americas
Exhibit 30: STD testing market in EMEA 2017-2022 ($ billions)
Exhibit 31: STD testing market in EMEA: YoY growth 2018-2022 (%)
Exhibit 32: Top three countries in EMEA
Exhibit 33: STD testing market in APAC 2017-2022 ($ billions)
Exhibit 34: STD testing market in APAC: YoY growth 2018-2022 (%)
Exhibit 35: Top three countries in APAC
Exhibit 36: Market opportunity
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: Vendor overview
Exhibit 43: Abbott: Business segments
Exhibit 44: Abbott: Organizational developments
Exhibit 45: Abbott: Geographic focus
Exhibit 46: Abbott: Segment focus
Exhibit 47: Abbott: Key offerings
Exhibit 48: Vendor overview
Exhibit 49: bioMerieux: Business segments
Exhibit 50: bioMerieux: Organizational developments
Exhibit 51: bioMerieux: Geographic focus
Exhibit 52: bioMerieux: Segment focus
Exhibit 53: bioMerieux: Key offerings
Exhibit 54: Vendor overview
Exhibit 55: Bio-Rad laboratories: Business segments
Exhibit 56: Bio-Rad laboratories: Organizational developments
Exhibit 57: Bio-Rad Laboratories: Geographic focus
Exhibit 58: Bio-Rad Laboratories: Segment focus
Exhibit 59: Bio-Rad laboratories: Key offerings
Exhibit 60: Vendor overview
Exhibit 61: F. Hoffmann La Roche: Business segments
Exhibit 62: F. Hoffmann La Roche: Organizational developments
Exhibit 63: F. Hoffmann La Roche: Geographic focus
Exhibit 64: F. Hoffmann La Roche: Segment focus
Exhibit 65: F. Hoffmann La Roche: Key offerings